Intelligence for decisions, partnerships and market expansion.
Economic reporting from around the world, filtered to the sectors and policy areas our members build in — part of the same intelligence stream behind the Global Economic Outlook and NiDCC's market reports.
ARS Pharmaceuticals' President and CEO, Donn Casale, was granted a stock option for 1,036,923 shares with an exercise price of $4.12 per share. A quarter of these shares will vest...
ProMIS Neurosciences Inc. has appointed Ivana Rubino, Ph.D., as Chief Commercial Officer, effective October 5, 2026. Dr. Rubino brings over 15 years of global biopharmaceutical lea...
CVS Health has scheduled November 4, 2026, for its third-quarter results following a strong second quarter where it reported adjusted EPS of USD 2.58, above consensus. Analysts mai...
Supernus Pharmaceuticals, Inc. filed a Form 425 to amend and supplement its definitive joint proxy statement/prospectus related to its proposed merger with Indivior Pharmaceuticals...
Neuronetics (STIM) stock rose 1.85% after reporting Q2 2026 revenue of $41.57 million, surpassing estimates by 3.20%. The company also narrowed its adjusted loss to $0.05 per share...
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's PPD clinical research business for its Phase 2 multiple sclerosis trial, Lucid-MS. This foll...
Regeneron Pharmaceuticals, Inc. announced promising new clinical data at the European Society for Medical Oncology (ESMO) Congress 2026, focusing on its cancer treatment Libtayo. T...
ProMIS Neurosciences Inc. (PMN) has appointed Ivana Rubino, Ph.D., formerly a Vice President at Biogen, as its new Chief Commercial Officer. In this role, Dr. Rubino will lead the...
Argus has upgraded Regeneron stock from Hold to Buy, setting an USD 850.00 price target after the company expanded its antibody collaboration with Sanofi, securing USD 1.0 billion...
ProMIS Neurosciences has appointed Ivana Rubino, Ph.D., as Chief Commercial Officer, effective October 5, 2026. Dr. Rubino, a former senior Biogen and Roche executive, brings over...